FibroGen Inc’s recently made public that its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun 12 ’24. In the deal valued at $1.17 per share,22,123 shares were bought. As a result of this transaction, Adib Deyaa now holds 82,123 shares worth roughly $73089.47.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Wettig Thane bought 50,000 shares, generating $95,470 in total proceeds. Upon buying the shares at $1.91, the CEO now owns 470,178 shares.
Before that, Henderson Jeffrey William sold 2,000 shares. FibroGen Inc shares valued at $2,060 were divested by the Director at a price of $1.03 per share. As a result of the transaction, Henderson Jeffrey William now holds 28,866 shares, worth roughly $25690.74.
BofA Securities downgraded its FibroGen Inc [FGEN] rating to an Underperform from a a Neutral in a research note published on August 08, 2023; the price target was decreased to $2 from $4. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in late June from “an Outperform” to “a Mkt perform”. Stifel also remained covering FGEN and has decreased its forecast on June 26, 2023 with a “Hold” recommendation from previously “Buy” rating. Raymond James revised its rating on June 26, 2023. It rated FGEN as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of FGEN
On Friday, FibroGen Inc [NASDAQ:FGEN] saw its stock fall -13.37% to $0.89. Over the last five days, the stock has lost -21.04%. FibroGen Inc shares have risen nearly 0.68% since the year began. Nevertheless, the stocks have fallen -64.16% over the past one year. While a 52-week high of $3.02 was reached on 02/12/24, a 52-week low of $0.33 was recorded on 01/05/24. SMA at 50 days reached $1.1512, while 200 days put it at $1.1613. A total of 15.14 million shares were traded, compared to the trading of 1.42 million shares in the previous session.
Levels Of Support And Resistance For FGEN Stock
The 24-hour chart illustrates a support level at 0.8411, which if violated will result in even more drops to 0.7898. On the upside, there is a resistance level at 0.9948. A further resistance level may holdings at 1.0972. The Relative Strength Index (RSI) on the 14-day chart is 32.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1052, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 100.00%. Stochastics%K at 34.02% indicates the stock is a holding.
